story of the week
Neratinib Efficacy and ctDNA Detection of HER2 Mutations in HER2 Non-Amplified Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer
Clin. Cancer Res 2017 Aug 15;[EPub Ahead of Print], CX Ma, R Bose, F Gao, RA Freedman, ML Telli, G Kimmick, E Winer, M Naughton, MP Goetz, C Russell, D Tripathy, M Cobleigh, A Forero, TJ Pluard, C Anders, PA Niravath, S Thomas, J Anderson, C Bumb, KC Banks, RB Lanman, R Bryce, AS Lalani, J Pfeifer, DF Hayes, M Pegram, K Blackwell, PL Bedard, H Al-Kateb, MJC EllisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.